Company Filing History:
Years Active: 2010
Title: Innovations in Cancer Treatment by Henry A Charlier, Jr.
Introduction
Henry A Charlier, Jr. is a notable inventor based in Boise, ID (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, his work focuses on improving the efficacy and safety of anthracycline drugs used in chemotherapy.
Latest Patents
Charlier's latest patents include groundbreaking compositions aimed at reducing cardiotoxicity in cancer patients undergoing chemotherapy. One of his patents, titled "Biphenyl inhibitors of carbonyl reductase - Compositions of matter and methods of treating cancer patients," outlines methods to prevent or limit cardiotoxicity during or after chemotherapy. This invention may also help lower resistance to anthracycline drugs, which is often caused by the human enzyme carbonyl reductase. The preferred embodiments of this patent involve treating patients with pharmaceutical compositions that include biphenyl compounds, such as triclosan, hexachlorophene, and dichlorophene.
Another significant patent is focused on "Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines." This invention aims to prevent or limit cardiotoxicity during treatment with anthracycline drugs. The preferred compositions include halogenated arylcyanooximes or phenylcyanooximes, which can be administered alongside anthracycline compounds.
Career Highlights
Henry A Charlier, Jr. is affiliated with Boise State University, where he conducts his research and develops his innovative solutions for cancer treatment. His work has garnered attention for its potential to improve patient outcomes and reduce the side effects associated with chemotherapy.
Collaborations
Charlier collaborates with esteemed colleagues, including Christopher K Ewing and Nikolay Gerasimchuk, to further advance his research and innovations in the field of cancer treatment.
Conclusion
Henry A Charlier, Jr. is a pioneering inventor whose work in cancer treatment is making a significant impact. His innovative patents aim to enhance the safety and effectiveness of chemotherapy, ultimately benefiting patients worldwide.